281 related articles for article (PubMed ID: 34629431)
1. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
[TBL] [Abstract][Full Text] [Related]
2. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
[TBL] [Abstract][Full Text] [Related]
3. Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China.
Yao H; An Y; Zhang H; Ren M; Chen CC; Xu Q; Wang Q; Zhang Z;
Dis Colon Rectum; 2021 Feb; 64(2):190-199. PubMed ID: 33395134
[TBL] [Abstract][Full Text] [Related]
4. Completion Surgery in Unfavorable Rectal Cancer after Transanal Endoscopic Microsurgery: Does It Achieve Satisfactory Sphincter Preservation, Quality of Total Mesorectal Excision Specimen, and Long-term Oncological Outcomes?
Serra-Aracil X; Galvez Saldaña A; Mora-Lopez LL; Montes N; Pallisera-Lloveras A; Serra-Pla S; Pericay C; Navarro-Soto S
Dis Colon Rectum; 2021 Feb; 64(2):200-208. PubMed ID: 33315715
[TBL] [Abstract][Full Text] [Related]
5. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the Circumferential Resection Margin After Curative Surgery for Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
Galvez A; Biondo S; Trenti L; Espin E; Kraft M; Farres R; Codina-Cazador A; Flor B; Garcia-Granero E; Enriquez-Navascues JM; Borda-Arrizabalaga N; Kreisler E
Dis Colon Rectum; 2023 Jul; 66(7):887-897. PubMed ID: 35348529
[TBL] [Abstract][Full Text] [Related]
7. Anastomosis-Related Complications After Stapled Anastomosis With Reinforced Sutures in Transanal Total Mesorectal Excision for Low Rectal Cancer: A Retrospective Single-Center Study.
Enomoto H; Ito M; Sasaki T; Nishizawa Y; Tsukada Y; Ikeda K; Hasegawa H
Dis Colon Rectum; 2022 Feb; 65(2):246-253. PubMed ID: 34657080
[TBL] [Abstract][Full Text] [Related]
8. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and Cost Analysis of Robotic Versus Laparoscopic Abdominoperineal Resection for Rectal Cancer: A Case-Matched Study.
Gorgun E; Cengiz TB; Ozgur I; Dionigi B; Kalady MF; Steele SR
Dis Colon Rectum; 2022 Oct; 65(10):1279-1286. PubMed ID: 35195554
[TBL] [Abstract][Full Text] [Related]
10. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
[TBL] [Abstract][Full Text] [Related]
11. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
Park SY; Lee SM; Park JS; Kim HJ; Choi GS
Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
[TBL] [Abstract][Full Text] [Related]
12. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
[TBL] [Abstract][Full Text] [Related]
13. Transanal Total Mesorectal Excision Versus Anterior Total Mesorectal Excision for Rectal Cancer: A Propensity Score Matched, Population-Based Study in Catalonia, Spain.
Manchon-Walsh P; de Lacy FB; Pera M; Espin-Basany E; Targarona EM; Biondo S; Aliste Sanchez L; Pallarès N; Tebé C; Pata F; Lacy AM; Guarga A; Borràs JM
Dis Colon Rectum; 2022 Feb; 65(2):207-217. PubMed ID: 34636779
[TBL] [Abstract][Full Text] [Related]
14. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
[TBL] [Abstract][Full Text] [Related]
15. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
Brachet S; Meillat H; Chanez B; Ratone JP; Brunelle S; Tyran M; Poizat F; de Chaisemartin C; Lelong B
Dis Colon Rectum; 2022 Dec; 65(12):1464-1474. PubMed ID: 35913830
[TBL] [Abstract][Full Text] [Related]
16. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Positive Circumferential Resection Margin in Rectal Cancer: A Current Audit of the National Cancer Database.
Simon HL; de Paula TR; Profeta da Luz MM; Kiran RP; Keller DS
Dis Colon Rectum; 2021 Sep; 64(9):1096-1105. PubMed ID: 33951688
[TBL] [Abstract][Full Text] [Related]
18. Advanced Lymph Node Staging With Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision for Rectal Cancer: A Retrospective Cohort Study.
Widmann B; Almarie B; Warschkow R; Beutner U; Weitzendorfer M; Schmid MB; Ukegjini K; Brunner W
Dis Colon Rectum; 2022 Aug; 65(8):1015-1024. PubMed ID: 34856584
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
[TBL] [Abstract][Full Text] [Related]
20. Sequential Lateral Lymphatic Metastasis Shows Similar Oncologic Outcomes to Upward Spread in Advanced Rectal Cancer After Preoperative Chemoradiotherapy.
Kim HJ; Choi GS; Cho SH; Kang MK; Park JS; Park SY; Kang BW; Kim JG
Dis Colon Rectum; 2024 Mar; 67(3):359-368. PubMed ID: 37962146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
